You Are Here: Home > Get Involved > Participate > Find an Event Near You > Canadian Arthritis Research Conference: Research with Impact
Go Back to Events

Canadian Arthritis Research Conference: Research with Impact

February 16 & 17, 2021

photo to supplement event

February 16, 2021

$25 until January 19th, $50 late fee.
Consumers should contact for complimentary registration. Space is limited and will be filled in order requests are received.

Industry participation at the Canadian Arthritis Research Conference is reserved for conference sponsors exclusively.

Virtual Event

Canadian Arthritis Research Conference

Join us ONLINE for the VIRTUAL Canadian Arthritis Research Conference (CARC) on February 16 & 17, 2021.

The Arthritis Society, Canadian Rheumatology Association (CRA) and CIHR-IMHA, are proud to bring together researchers, clinicians and individuals living with arthritis to explore perspectives, advance knowledge and enhance Canadian leadership in the world of arthritis and rheumatic diseases.

Building on the success of the 2020 conference, we are assembling experts and stakeholders to further advance research in the areas of arthritis and rheumatic diseases to better the health of Canadians. The overarching goal is to improve the health of those living with arthritis. 

CARC 2021 provides two days of quality content relating to both osteoarthritis and inflammatory arthritis. In addition to keynote and invited presentations, CARC 2021 provides a forum for investigators to share original research. 

Updated: Researchers in all areas of RA and OA are welcomed to submit their abstracts by January 22, 2021 for poster presentations and are asked to ensure they have also registered for the conference. The top eight abstract submissions will be invited to speak at the Canadian Arthritis Research Conference on February 16-17, 2021. In addition, this year’s conference will include an Original Research Presentation Day on February 5, 2021 where researchers who have submitted an abstract will be invited to give a 10-minute presentation on their original research. This Original Research Day will be an opportunity to foster collaboration and facilitate knowledge translation among the arthritis research community. 

This is an opportunity for knowledge exchange for a variety of stakeholders including primary care providers, allied healthcare providers, researchers, policy-makers, community partners, and individuals with lived experience over a two-day virtual conference.


  • Bring together national and international leaders, knowledge-users, and individuals with lived experience to strengthen our capacity to develop and disseminate strategies for improved care across the arthritis and rheumatic disease spectrum.
  • Identify emerging areas in research and clinical practice centered on arthritis and rheumatic conditions affecting patients across their lifespan.
  • Delineate strategies to address gaps in research and clinical practice for arthritis and rheumatic diseases.
  • Promote networking among clinicians, scientists, policy-makers and individuals with lived experience, facilitating translation of knowledge that will ultimately improve the health of Canadians.

Any questions or comments can be directed to


Day 1 – Tuesday, February 16, 2021 

Day 1 of CARC 2021 will feature 12 concurrent presentations that focus on Medicine and Rheumatoid Arthritis (Room 1) and Rehabilitation and Osteoarthritis (Room 2). Day 1 keynote speakers, Dr. Christine Chambers and Isabel Jordan, will be presenting their session, “Worlds Colliding: Lessons Learned Through Partnering with Patients & Caregivers to Improve Health Research and Care” from 11:55 – 12:25 pm EST (25 min + 5 min Q&A). 

  • Room 1 Focus: Medicine, Rheumatoid Arthritis

    Dr. Jennifer Anolik
    12:30 – 1:00 EST (25 min + 5 min Q&A)
    Session title:
    Unexpected features in the rheumatoid arthritis synovium revealed by the Accelerating Medicines Partnership

    Dr. Dawn Richards
    1:00 – 1:30 EST (25 min + 5 min Q&A)
    Session title: Patient Engagement in Research: Why and How

    Dr. Costantino Pitzalis
    1:30 – 2:00 EST (25 min + 5 min Q&A)
    Session title: Molecular Portraits of Rheumatoid Arthritis: Defining Clinical and Treatment Response Endo-Phenotypes Towards Precision Medicine

    Best Original Research Presentations (Rheumatoid Arthritis)
    Etienne Dore  
    14:15-14:30 EST (10 min + 5 Q&A) 
    Session title: An endogenous enzyme promotes arthritis severity through the intestinal flora 

    Arif Jetha 
    14:30-14:45 EST
    (10 min + 5 Q&A) 
    Session title: Impact of the COVID-19 pandemic on the employment of Canadian young adults with rheumatic disease: longitudinal survey findings 

    Panel: Ask Me Anything
    2:45 – 3:15
    Chair: Dr. Marie Hudson

  • Room 2 Focus: Rehabilitation, Osteoarthritis 

    Dr. Ewa Roos  
    12:30 – 1:00 EST (25 min + 5 min Q&A) 
    Session title: Is OA a Disease or an Illness? Implication for Treatment and Prevention 

    Dr. Jackie Whittaker 
    1:00 – 1:30 EST
    (25 min + 5 min Q&A) 
    Session title: Time waits for no-one: Preventing OA after a Joint Injury 

    Dr. Kay Crossley  
    1:30 – 2:00 EST (25 min + 5 min Q&A) 
    Session title: Preventing Sport-related Joint Injuries: An Ounce of Prevention is Worth a Pound of Cure 

    Best original Research Presentations (Osteoarthritis) 
    Linda Truong 
    14:15-14:30 EST (10 min + 5 Q&A) 
    Session title: “Arthritis is always in the back of my mind.” A qualitative study describing youth’s attitudes, priorities, and perceptions towards physical activity and exercise-therapy after a sport-related anterior cruciate ligament tear 

    Rachael Manion 
    14:30-14:45 EST (10 min + 5 Q&A) 
    Session title: Impacts of COVID-19 on the Psoriasis & Psoriatic Arthritis Community in Canada: Highlights from a National Survey 

    Panel: Ask Me Anything 
    2:45 – 3:15 Chair: Dr. Karim Khan & Christina Le

Day 2 – Wednesday, February 17, 2021 


Day 2 of CARC 2021 will feature twelve concurrent presentations that focus on Medicine and Osteoarthritis (Room 1) and Rehabilitation and Rheumatoid Arthritis (Room 2). Day 2 keynote speaker, Dr. Gillian Hawker, will be presenting, “Osteoarthritis: A not-so-silent killer” from 1:35 – 2:05 pm EST. 

  • Room 1 Focus: Medicine, Osteoarthritis

    Dr. Margreet Kloppenburg  
    12:00 – 12:30 EST (25 min + 5 min Q&A) 
    Session title: Hand Osteoarthritis: New Horizons

    Dr. Mohit Kapoor  
    12:30 – 1:00 EST (25 min + 5 min Q&A) 
    Session title: Using high throughput, multi-omics approach to decode osteoarthritis 

    Dr. Philip Conaghan  
    1:00 – 1:30 EST (25 min + 5 min Q&A) 
    Session title: What new therapies are being trialed for OA? 

    Best Original Research Presentations (Osteoarthritis) 
    Hosni Cherif 
    14:15-14:30 EST (10 min + 5 Q&A) 
    Session title: New diagnostic and therapeutic tools for intervertebral disc degeneration and back pain 

    Juan Manuel Colazo 
    14:30-14:45 EST (10 min + 5 Q&A) 
    Session title: Bioengineered siRNA Delivery Platforms Provide Prolonged MMP13 Silencing for the Prevention and Treatment of Post-Traumatic Osteoarthritis (PTOA) 

    Panel: Ask Me Anything 
    2:45 – 3:15 EST 
    Chair: Dr. Marie Hudson & Dr. Amanda Ali

  • Room 2 Focus: Rehabilitation, Rheumatoid Arthritis

    Eileen Davidson  
    12:00 – 12:30 EST (25 min + 5 min Q&A) 
    Session title: The Truth about Life with RA: A Patient Perspective of Daily Living with RA (25 min + 5 min Q&A) 

    Dr. Linda Li  
    12:30 – 1:00 EST (25 min + 5 min Q&A) 
    Session title: Treat-to-Target: The Roles of Self-monitoring and Balanced-activity Counselling in Rheumatoid Arthritis Care 

    Dr. Deborah Da Costa  
    1:00 – 1:30 EST (25 min + 5 min Q&A) 
    Session title: Sleep Management in Rheumatoid Arthritis  (25 min + 5 min Q&A) 

    Best Original Research Presentations (Rheumatoid Arthritis) 
    Karine Toupin April & Laurie Proulx 
    14:15-14:30 EST (10 min + 5 Q&A) 
    Session title: Development and preliminary acceptability and usability of the JIA Option Map, a Web-based Patient Decision Aid for Pain Management in Juvenile Idiopathic Arthritis 

    Michelle Barraclough 
    14:30-14:45 EST (10 min + 5 Q&A) 
    Session title: Altered Brain Functional Connectivity in Systemic Lupus Erythematosus and the Impact of Depression 

    Panel: Ask Me Anything 
    2:45 – 3:15 EST 
    Dr. Jackie Whittaker & Dr. Jasmin Ma

Full Schedule [266 kB]

Original Research Presentation Day

In conjunction with the main conference, there will be an Original Research Presentation Day [514 kb] on February 5, 2021 from 8:30-1:40 PST/11:30-4:40 EST. All stakeholders from the arthritis research community are welcome to register for this additional presentation day to view presentations of original research in the area of arthritis and rheumatic diseases.

Call for Abstracts
  • Poster Session Booklet

    You will find in the booklet below the list of poster presenters in the 2021 Canadian Arthritis Research Conference.

    Poster Session Booklet [2.4 MB]

  • Important Dates

    January 22, 2021: All abstracts must be received via the submission form before 10 AM on January 22, 2021. Incomplete or late submissions will not be accepted.  Authors will receive an email confirming the receipt of their submission and confirming it meets minimum requirements. 

    IMPORTANT: Space is limited. We are only able to accept the first 50 abstracts submitted via email. Please submit your abstract as soon as possible. 

    Update: January 27, 2021: Notification of acceptance of abstracts for poster presentations. Notification of the winners of the 8 presentation slots for the CARC 2021 conference. Note: all accepted abstracts will be invited to submit a poster to the CARC virtual poster room where attendees can browse the poster PDFs and ask questions throughout the conference. 

    Update: February 5, 2021: Authors of accepted abstracts are invited to conduct a 10-minute presentation of their work on February 5. This will be a chance to share knowledge and communicate with the research community. 

  • Call for Abstracts

    The Arthritis Society, Canadian Rheumatology Association and the Canadian Institutes of Research - Institute of Musculoskeletal Heath and Arthritis invite researchers to submit abstracts for presentation at the second annual Canadian Arthritis Research Conference. Researchers at all career stages – including PI’s and trainees – are encouraged to submit abstracts. Abstracts describing original biomedical, clinical, health systems and population health related to the broad area of arthritis and rheumatic disease may be submitted.  

    The conference will feature a range of exciting presentations, discussions, and networking opportunities with experts, researchers, consumers and up-and-coming leaders in the field of arthritis.

    This is an opportunity to share your work with colleagues from across Canada who are actively pursuing advances in arthritis research. 

    There is limited space and abstracts will be selected based on the order in which they are received and reviewed for relevance. 

  • Submissions – Now Closed

    When submitting your abstract, please indicate in your email if you are interested in doing both the Original Research Day presentation and the CARC poster session, or just the CARC poster session.

    submissions now closed

  • Prizes

    Update: The top 8 abstract submissions will be awarded spaces to present as a speaker at the Canadian Arthritis Research Conference on February 16-17, 2021. All accepted abstracts will be invited to present on the Original Research Day on February 5 and to the poster session occurring at the Canadian Arthritis Research Conference.

  • Requirements

    All submissions must include:

    • A clear and concise abstract of no more than 400 words in English or French that satisfies requirements for scholarly rigour
    • A title 
    • A list of all authors using their full names and include their most current email address
    • Institution affiliations for each author
    • Indication of CIHR pillar (I biomedical; II clinical; III health systems and services; or IV population, societal, cultural, environmental)
    • Disclosure of any conflicts of interest
    • Note: All accepted abstracts may be made available to conference attendees and on-line after the conference. Please share your preference for your work to be included on-line.

    Organize content in sections as follows:

    • Background/purpose
    • Methods
    • Results
    • Discussion/Conclusion
  • Presentation Details
    • As this is a virtual conference, posters must fit onto a PDF page. Specific details will be shared in the information for successful applicants.
  • Disclosures

    Authors are responsible for reporting any real or perceived financial conflict of interest. A brief disclosure and conflict of interest statement should be submitted with the abstract and viewable on the poster. Any potential for financial gain that may be derived from reported work may constitute a possible conflict of interest. Disclosure is required in any case in which an individual or company stands to benefit financially from research performed. Therefore, each author must indicate any benefit to an individual or company that may potentially lead to financial reward.

    A “financial interest” may include but is not limited to:

    • being a shareholder
    • receiving research funding or other support
    • receiving fees or other benefits for any role (including speaking at CPD activities)
    • being a paid employee or consultant

    An “affiliation” may include but is not limited to:

    • holding a position in the organization
    • sitting on an advisory committee
    • playing some other role of benefit to the organization

    Disclosures should appear on the bottom left corner of the poster and may follow the recommended format: "Disclosures: None" or "Disclosures: The author(s) disclose a relationship with..."

  • Important Note

    Please note that abstracts that have been submitted to the 2021 Canadian Rheumatology Association and Arthritis Health Professionals Association Annual Scientific Meeting are not eligible for submission.


The Arthritis Society, Canadian Rheumatology Association (CRA) and CIHR-IMHA would like to thank our corporate sponsors for their generous support of this program.

Research Champion

Logo of abbvie

Logo of Fresenius Kabi

Logo of Medexus Pharma - Medexus Pharmaceuticals Inc.

Research Supporter

Logo of Janssen - Pharmaceutical Companies of Johnson & Johnson

Logo of ucb

Logo for the Annual Scientif Meeting with the CRA SCR and AHPA
Please also consider attending The Canadian Rheumatology Association (CRA) Annual Scientific Meeting, February 24-26, 2021